mechanism 2,240 words KG: ent-gene-961a77ee 2026-04-01
kind:section:mechanismsevidence:strongmechanismsection:mechanismsstate:publishedalzheimeramyloidappbace1
Contents

APP-BACE1-Fe65 Complex

🔬 Protein Info
Gene SymbolAPP
Full NameBACE1-Fe65 Complex
Chromosome21q21.3
Protein TypeProtein
Functionis a type I transmembrane glycoprotein that plays a central role in the pathogenesis of Alzheimer's disease (AD).
Primary ExpressionUbiquitous, highest in brain
Subcellular Localizationof APP processing is critical—BACE1 activity is highest in lipid rafts, specialized membrane microdomains rich in choles
Molecular Weight~110 kDa
Exons18
PathwaysAmyloid, Angiogenesis, Apoptosis, Autophagy, Blood-Brain Barrier
UniProt IDP05067
NCBI Gene ID351
Ensembl IDENSG00000142192
OMIM104760
GeneCardsAPP
Human Protein AtlasAPP
Associated DiseasesAD, ALS, AMI, AMYLOIDOSIS, ASTROGLIOSIS, ATHEROSCLEROSIS
Known Drugs/CompoundsLIRAGLUTIDE, DASATINIB, RAPAMYCIN, DIMETHYL FUMARATE, NICOTINAMIDE, MEMANTINE
InteractionsEIF2AK2, S100B, C1Q, TGM2, GPNMB, HMGB1
SciDEX HypothesesSelective Cholinergic Protection via APP Pathway M
KG Connections4431 knowledge graph edges
DatabasesGeneCardsHPASTRING

Knowledge Graph

Related Hypotheses (14)

Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa
Score: 0.70
Selective Cholinergic Protection via APP Pathway Modulation
Score: 0.43
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54

Related Analyses (30)

CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed

Related Experiments (24)

Plasma ATN biomarkers across AD continuum in Chilean cohort
clinical · proposed · Score: 0.95
Creation and validation of 3xAD-ChAT-Cre mouse model
validation · proposed · Score: 0.90
Adoptive transfer of TCRAβ-Tregs in AD mouse model
validation · proposed · Score: 0.90
Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's diseas
validation · proposed · Score: 0.95
Anti-ASC antibody intracerebroventricular injection in APP/P
validation · proposed · Score: 0.95

Knowledge Graph (4 edges)

ent-gene-961a77ee data_in ad_genetic_risk_loci:APP
ent-gene-961a77ee data_in benchmark_ot_ad_answer_key:APP
ad_genetic_risk_loci:APP data_in ent-gene-961a77ee
benchmark_ot_ad_answer_key:APP data_in ent-gene-961a77ee